Retatrutide is a triple glucagon hormone receptor agonist targeting three key metabolic receptors — GLP-1, GIP, and GCGR — simultaneously. Research suggests it is more effective for body fat mass reduction than Semaglutide (a single-receptor agonist) by engaging additional pathways involved in energy homeostasis and fat metabolism.
Key Benefits
Triple-receptor agonism: GLP-1, GIP, and GCGR pathways simultaneously
Superior fat mass reduction compared to single-receptor agonists in research settings
Metabolic regulation through multiple simultaneous mechanisms
Studied for obesity and metabolic syndrome applications
Reconstitution
Add 1mL bacteriostatic water to achieve a 10mg/mL concentration.
Each 0.1mL of solution contains 1mg of Retatrutide.
Swirl gently — do not shake. Allow to fully dissolve.
Storage
Must be refrigerated after reconstitution. Store lyophilized powder below 25°C, away from light. Do not freeze reconstituted solution.
For laboratory research use only. Not for human or veterinary use.